DMT210 Topical Gel in the Treatment of Acne Rosacea
Public ClinicalTrials.gov record NCT03003104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea
Study identification
- NCT ID
- NCT03003104
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Dermata Therapeutics
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- DMT210 Topical Gel 5% Drug
- Vehicle Control Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2016
- Primary completion
- Aug 29, 2017
- Completion
- Aug 29, 2017
- Last update posted
- Apr 17, 2018
2017
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermata Investigational Site | San Diego | California | — | — |
| Dermata Investigational Site | Miami | Florida | — | — |
| Dermata Investigational Site | Fridley | Minnesota | — | — |
| Dermata Investigational Site | Omaha | Nebraska | — | — |
| Dermata Investigational Site | High Point | North Carolina | — | — |
| Dermata Investigational Site | Broomall | Pennsylvania | — | — |
| Dermata Investigational Site | Nashville | Tennessee | — | — |
| Dermata Investigational Site | Austin | Texas | — | — |
| Dermata Investigational Site | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03003104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03003104 live on ClinicalTrials.gov.